BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Anticancer prodrugs
,
Phenobarbital
,
rs3825942
,
ZBTB7A
,
calcium channel activity
,
Lung
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
KCa3 1
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for KCa3 1
Explore Curated Studies Results
Literature
Most Relevant Literature
The erythroid K-Cl cotransport inhibitor [(dihydroindenyl)oxy]acetic acid blocks erythroid Ca2+-acti…
Dextran sodium sulfate potentiates NLRP3 inflammasome activation by modulating the KCa3.1 potassium …
Lack of Kcnn4 improves mucociliary clearance in muco-obstructive lung disease.
KCa3.1 inhibition-induced activation of the JNK/c-Jun signaling pathway enhances IL-10 expression in…
KCa3.1 channel mediates inflammatory signaling of pancreatic β cells and progression of type 2 diabe…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Targeting Potassium Channels to Reprogram Glioblastoma Microenvironment: in Vitro and in Vivo Studie…
Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency
Risk Factors of Neonatal Respiratory Distress for Newborns With Prenatally Diagnosed Congenital Lung…
Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma
Safety and Efficacy Study of Oral Senicapoc on Allergen Challenge in Atopic Asthmatic Subjects
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ